SURAKSHA DIAGNOSTIC
|
SURAKSHA DIAGNOSTIC Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 6.18 | 6.11 | 342.40 | 94.43 | 344.20 |
| CEPS(Rs) | 13.99 | 12.73 | 807.60 | 546.90 | 562.91 |
| DPS(Rs) | 0.50 | - | - | - | - |
| Book NAV/Share(Rs) | 46.81 | 40.52 | 2,576.52 | 2,236.19 | 2,149.92 |
| Tax Rate(%) | 29.52 | 25.18 | 26.47 | 10.12 | 28.45 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 30.98 | 32.50 | 32.41 | 23.37 | 21.54 |
| EBIT Margin(%) | 18.65 | 20.02 | 18.77 | 8.58 | 15.81 |
| Pre Tax Margin(%) | 14.35 | 16.42 | 14.38 | 3.55 | 14.87 |
| PAT Margin (%) | 10.12 | 12.29 | 10.57 | 3.19 | 10.64 |
| Cash Profit Margin (%) | 23.47 | 26.29 | 25.48 | 19.85 | 17.40 |
| Performance Ratios | |||||
| ROA(%) | 8.04 | 9.78 | 7.96 | 2.52 | 12.78 |
| ROE(%) | 13.81 | 15.93 | 13.93 | 4.01 | 17.40 |
| ROCE(%) | 24.97 | 24.92 | 22.94 | 9.62 | 22.65 |
| Asset Turnover(x) | 0.79 | 0.80 | 0.75 | 0.79 | 1.20 |
| Sales/Fixed Asset(x) | 0.80 | 0.85 | 0.87 | 0.87 | 1.09 |
| Working Capital/Sales(x) | 106.04 | 56.83 | 6.62 | 6.40 | -35.44 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.25 | 1.18 | 1.14 | 1.15 | 0.92 |
| Receivable days | 21.50 | 16.42 | 11.31 | 11.76 | 11.09 |
| Inventory Days | 9.52 | 10.66 | 10.71 | 11.89 | 8.72 |
| Payable days | 172.64 | 173.33 | 190.40 | 185.93 | 80.01 |
| Valuation Parameters | |||||
| PER(x) | 36.90 | 42.19 | - | - | - |
| PCE(x) | 16.30 | 20.26 | - | - | - |
| Price/Book(x) | 4.87 | 6.36 | - | - | - |
| Yield(%) | 0.22 | - | - | - | - |
| EV/Net Sales(x) | 3.75 | 5.27 | -0.17 | -0.17 | 0.11 |
| EV/Core EBITDA(x) | 11.71 | 15.49 | -0.51 | -0.68 | 0.49 |
| EV/EBIT(x) | 20.09 | 26.31 | -0.92 | -1.99 | 0.70 |
| EV/CE(x) | 4.72 | 6.12 | -0.20 | -0.19 | 0.15 |
| M Cap / Sales | 3.83 | 5.33 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 23.13 | 15.26 | 15.03 | -14.81 | 59.42 |
| Core EBITDA Growth(%) | 15.82 | 15.24 | 55.14 | -4.78 | 110.05 |
| EBIT Growth(%) | 14.69 | 22.95 | 151.76 | -53.80 | 326.43 |
| PAT Growth(%) | 1.37 | 33.95 | 281.31 | -74.46 | 269.06 |
| EPS Growth(%) | 1.14 | -98.22 | 262.58 | -72.56 | 269.06 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.03 | 0.05 | 0.09 | 0.13 |
| Current Ratio(x) | 1.05 | 1.10 | 1.84 | 1.77 | 0.78 |
| Quick Ratio(x) | 0.91 | 0.92 | 1.67 | 1.61 | 0.55 |
| Interest Cover(x) | 4.34 | 5.56 | 4.27 | 1.71 | 16.78 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of SURAKSHA DIAGNOSTIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SURAKSHA DIAGNOSTIC | ₹1,672.9 Cr | -4.7% | 5.7% | 7.8% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹125,093.0 Cr | 1% | 3% | 14% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹99,963.8 Cr | 4.7% | 2.8% | -9.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹66,360.8 Cr | -2.3% | -1.9% | -4.3% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹64,704.2 Cr | -4.1% | -7.4% | 20.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,755.0 Cr | -2.3% | 2% | 7% | Stock Analytics | |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SURAKSHA DIAGNOSTIC | -4.7% |
5.7% |
7.8% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses
